A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer. - File DM; Abdou Y; Force J; Moore DT; Anders CK; Reeder-Hayes K; Carey LA; Muss HB; Perou CM; Marcom PK; Dees EC (Clinical breast cancer, 2024)